1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ah 23848 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ah 23848) | Trials (ah 23848) | Recent Studies (post-2010) (ah 23848) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 89 | 3 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wise, H | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ah 23848
Article | Year |
---|---|
Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
Topics: Animals; Biphenyl Compounds; Cell Aggregation; Cyclic AMP; Dinoprostone; Epoprostenol; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Rolipram | 1998 |